课题基金 / 基金详情

Genetic Regulation of Indoleamine-2,3-dioxygenase and Psychiatric Complications o

Genetic Regulation of Indoleamine-2,3-dioxygenase and Psychiatric Complications o
吲哚胺-2,3-双加氧酶的基因调控与精神并发症
批准号:
7799933
负责人:
Gregory F Oxenkrug
金额:
$20.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-03 至 2011-08-31

项目摘要

项目成果

Gregory F Oxenkrug的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):吲哚胺-2,3-双加氧酶的遗传调节和IFN-α治疗的精神并发症精神并发症是丙型肝炎的干扰素-α(IFN-α)治疗的常见副作用。文献表明,吲哚胺-2,3-双加氧酶(IDO)(色氨酸(TRY)代谢的犬尿氨酸途径的限速酶)的上调是在IFN-α治疗期间观察到的抑郁、焦虑和精神病的原因:a)IDO的活化使TRY代谢转向增加犬尿氨酸的产生,并且远离5-羟色胺(抗抑郁作用的主要底物)的合成;和B)犬尿氨酸代谢物具有致焦虑和拟精神病作用。IDO由促炎细胞因子转录诱导。IFN-α刺激IDO活性和IFN-γ(IFNG)(IDO的最强转录诱导物)和放大IFNG诱导的IDO表达的肿瘤坏死因子-α(TNF-α)的产生。IFNG(+874)(T/A)和TNF-α(-308)(A/G)基因型可能预先确定IFNG和TNF-α产生的水平,并因此预先确定IDO活性的程度和与IFN-α治疗相关的精神并发症的频率。我们认为IFNG的高启动子T(+874)与TNF-α的高启动子A(-308)等位基因的组合可能导致IDO的“超诱导”,因此,在IFN-α治疗的患者中增加精神并发症的风险。我们的工作假设是,具有IFNG(TT+TA)和TNF-α(AA+AG)的高启动子等位基因的组合的个体在IFN-α治疗的患有精神并发症的患者中比在没有精神并发症的患者中更普遍。我们提出了一个横断面回顾性研究IFNG(+874)(T/A)和TNF-α(-308)(A/G/)基因多态性在丙型肝炎患者和无精神并发症的IFN-α治疗的反应。获得的数据可能证明进一步研究基因型,细胞因子水平,IDO活性和精神并发症之间的关联,并提出预测和治疗丙型肝炎IFN-α治疗的精神并发症和其他IFN-α治疗的病症的新方法,例如,癌症、肌萎缩侧索硬化症和多发性硬化症。公共卫生相关性:该研究旨在调查细胞因子基因多态性分析是否有助于识别对IFN-α治疗有精神并发症高风险的丙型肝炎患者
英文摘要
DESCRIPTION (provided by applicant): Genetic regulation of indoleamine-2,3-dioxygenase and psychiatric complications of IFN-alpha therapy Psychiatric complications are the often side effects of interferon-alpha (IFN-alpha) therapy of hepatitis C. Literature suggests that the up-regulation of indoleamine-2,3-dioxygenase (IDO), the rate-limiting enzyme of the kynurenine pathway of tryptophan (TRY) metabolism, is responsible for the depression, anxiety, and psychosis observed during IFN-alpha therapy: a) activation of IDO shunts TRY metabolism to increased production of kynurenines, and away from synthesis of serotonin, the major substrate of antidepressant action; and b) kynurenine metabolites have anxiogenic and psychotomimetic effects. IDO is transcriptionally induced by pro-inflammatory cytokines. IFN-alpha stimulates IDO activity and production of IFN-gamma (IFNG) (the strongest transcriptional inducer of IDO), and of tumor necrosis factor-alpha (TNF-alpha) that amplifies IFNG-induced IDO expression. IFNG (+874) (T/A) and TNF-alpha(-308) (A/G) genotypes might predetermine the level of IFNG and TNF-alpha production, and, consequently, the degree of IDO activity and the frequency of psychiatric complications associated with IFN-alpha treatment. We suggest that combination of the high promoter T of IFNG (+874) with the high promoter A of TNF-alpha (-308) alleles might result in "super-induction" of IDO, and, therefore, in increased risk of psychiatric complications in IFN-alpha treated patients. Our working hypothesis is that individuals possessing a combination of high promoter alleles of IFNG (TT+TA) and TNF-alpha (AA+AG) are more prevalent among IFN-alpha treated patients with psychiatric complications than in patients without psychiatric complications. We propose a cross-sectional retrospective study of IFNG (+874)(T/A) and TNF-alpha(-308) (A/G/) gene polymorphisms in hepatitis C patients with and without psychiatric complications in response to IFN-alpha treatment. The obtained data might justify further studies of association between genotypes, cytokines levels, IDO activity and psychiatric complications, and suggest new ways of prediction and treatment of psychiatric complications of IFN-alpha therapy of hepatitis C and other IFN-alpha treated conditions, e.g., cancer, amyotrophic lateral sclerosis and multiple sclerosis. PUBLIC HEALTH RELEVANCE: The proposed study aims to investigate whether analysis of cytokine gene polymorphisms might help to identify hepatitis C patients with high risk of developing psychiatric complications in response to IFN-alpha therapy
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
DOI: 10.4236/ajps.2012.327123
发表时间: 2012-07
期刊: American journal of plant sciences
影响因子: --
作者: [Navrotskaya VV, Oxenkrug G, Vorobyova LI, Summergrad P]
通讯作者: Summergrad P
Serotonin-kynurenine hypothesis of depression: historical overview and recent developments.
抑郁症的血清素-犬尿氨酸假说:历史概述和最新发展。
DOI: 10.2174/1389450111314050002
发表时间: 2013-05-01
期刊: Current drug targets
影响因子: 3.2
作者: [Oxenkrug G]
通讯作者: Oxenkrug G
Minocycline effect on life and health span of Drosophila melanogaster.
米诺环素对果蝇生命和健康寿命的影响。
DOI: --
发表时间: 2012
期刊: Aging and disease
影响因子: 7.4
作者: [Oxenkrug,Gregory, Navrotskaya,Valeriya, Vorobyova,Lyudmila, Summergrad,Paul]
通讯作者: Summergrad,Paul
DOI: --
发表时间: 2010
期刊: The Israel journal of psychiatry and related sciences
影响因子: --
作者: [G. Oxenkrug]
通讯作者: G. Oxenkrug
共 7 条
    Depression, insulin resistance and xanthurenic acid in hepatitis C virus patients
    • 批准号:
      8772121
    • 项目类别:
    • 资助金额:
      $8.76万
    • 财政年份:
      2014
    • 负责人:
      Gregory F Oxenkrug
    • 依托单位:
    Neopterin and kynurenine as predictors of depression risk and antiviral efficacy
    • 批准号:
      8542902
    • 项目类别:
    • 资助金额:
      $7.63万
    • 财政年份:
      2012
    • 负责人:
      Gregory F Oxenkrug
    • 依托单位:
    Neopterin and kynurenine as predictors of depression risk and antiviral efficacy
    • 批准号:
      8430663
    • 项目类别:
    • 资助金额:
      $7.95万
    • 财政年份:
      2012
    • 负责人:
      Gregory F Oxenkrug
    • 依托单位:
    Genetic Regulation of Indoleamine-2,3-dioxygenase and Psychiatric Complications o
    • 批准号:
      7660194
    • 项目类别:
    • 资助金额:
      $24.15万
    • 财政年份:
      2009
    • 负责人:
      Gregory F Oxenkrug
    • 依托单位:
    海外基金